Pharmabiz

Bristol Myers Squibb data at ASH 2025 showcase potential of haematology pipeline and build momentum for next generation portfolio

Opdivo (nivolumab), in combination with Yervoy (ipilimumab), is indicated for the treatment of adult and paediatric patients 12 years and older with unresectable or metastatic microsatellite ...
Pharmabiz

Max Healthcare and Monash University sign MoU to advance research and academic collaboration

Max Healthcare and Monash University sign MoU to advance research and academic collaboration: Our Bureau, Mumbai Tuesday, December 2, 2025, 17:30 Hrs [IST] Max Healthcare, one of ...
Pharmabiz

Beyond Next Ventures backed Biomoneta bags US FDA approval for air-decontamination medical device

Beyond Next Ventures backed Biomoneta bags US FDA approval for air-decontamination medical device: Our Bureau, Bengaluru Tuesday, December 2, 2025, 17:20 Hrs [IST] Biomoneta, a pi ...
Pharmabiz

BPL Medical Technologies unveils OT charting software heralds the digital revolution in healthcare solutions

BPL Medical Technologies unveils OT charting software heralds the digital revolution in healthcare solutions: Our Bureau, Bengaluru Tuesday, December 2, 2025, 17:10 Hrs [IST] BPL ...
Pharmabiz

US FDA approves Cleveland Diagnostics’ novel blood-based prostate cancer test, IsoPSA

US FDA approves Cleveland Diagnostics’ novel blood-based prostate cancer test, IsoPSA: Cleveland Tuesday, December 2, 2025, 17:00 Hrs [IST] Cleveland Diagnostics, Inc., a pionee ...
Pharmabiz

Merck honours 16 scientists in its fourth edition of the Merck Young Scientist Award 2025

Merck honours 16 scientists in its fourth edition of the Merck Young Scientist Award 2025: Our Bureau, Bangalore Tuesday, December 2, 2025, 16:50 Hrs [IST] Merck, a leading scienc ...
Pharmabiz

Metropolis Healthcare unveils scientifically curated GLP-1 monitoring test packages to support safe metabolic care in India

Metropolis Healthcare unveils scientifically curated GLP-1 monitoring test packages to support safe metabolic care in India: Our Bureau, Bengaluru Tuesday, December 2, 2025, 16:40 ...
Pharmabiz

University of East Anglia research shows three-quarters of the world not getting enough omega-3

University of East Anglia research shows three-quarters of the world not getting enough omega-3: Our Bureau, Bengaluru Tuesday, December 2, 2025, 16:30 Hrs [IST] University of Eas ...
Pharmabiz

MediBuddy gears up to support corporates with new Labour Code mandate

MediBuddy gears up to support corporates with new Labour Code mandate: Our Bureau, Bengaluru Tuesday, December 2, 2025, 16:20 Hrs [IST] MediBuddy, India’s largest digital health ...
Pharmabiz

Tata Elxsi, Univ. of Illinois Urbana-Champaign & OSF HealthCare partner to transform rural healthcare access in US

Tata Elxsi, Univ. of Illinois Urbana-Champaign & OSF HealthCare partner to transform rural healthcare access in US: Our Bureau, Bengaluru Tuesday, December 2, 2025, 16:10 Hrs [IST ...
Pharmabiz

Agilent announces 21 CFR Part 11 compliance software for xCELLigence RTCA eSight

Agilent announces 21 CFR Part 11 compliance software for xCELLigence RTCA eSight: Santa Clara, California Tuesday, December 2, 2025, 16:00 Hrs [IST] Agilent Technologies Inc annou ...
Pharmabiz

Biocon Biologics secures market entry date for denosumab biosimilars in Europe and RoW

Biocon Biologics secures market entry date for denosumab biosimilars in Europe and RoW: Our Bureau, Mumbai Tuesday, December 2, 2025, 15:15 Hrs [IST] Biocon Biologics Ltd. (BBL), ...